Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
University of Pennsylvania Inc
Search grants from University of Pennsylvania Inc
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Penn State Clinical and Translational Science Institute
Inter-Relationships Between Life-Course Alcohol Patterns and Health Conditions
Cognitive Consequences of Emotion
Neural Crest and Enteric Nervous System Development
Multisite Young Autism Project
Recently added grants:
Balancing protective immunity and chronic sequelae by resident CD8 T cells
Elucidating Germinal Center-Mediated Antibody Evolution
Mechanisms of Intrinsic Host Responses to Hantavirus Infection
Administrative Core
Regulation of infection-associated protein expressed by the Lyme disease spirochete DnaA protein
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025118-002
Application #
6828862
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
University of Pennsylvania Inc
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2003
N01 CA
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
/ University of Pennsylvania Inc
NIH 2002
N01 CA
Phase I Single and Multiple-Dose Safety and Pharmacokinetic Clinical S-261025118
/ University of Pennsylvania Inc
Comments
Be the first to comment on this grant